Technology News and Research

RSS

Anova Cancer Care to participate in CyberKnife research study

Anova Cancer Care has been chosen to participate in a landmark national prostate cancer study. The goal of the two-year study is to determine the best treatments for prostate cancer. The study will look specifically at prostate cancer radiosurgery.

29 Aug 2012

Johns Hopkins' Armstrong Institute for Patient Safety and Quality receives Moore Foundation grant

Johns Hopkins' Armstrong Institute for Patient Safety and Quality has received an $8.9 million grant from the Gordon and Betty Moore Foundation, the first award given as part of an ambitious new $500 million, 10-year program designed to eliminate all preventable harms that patients experience in the hospital.

29 Aug 2012

HealthPartners receives Acclaim Award from American Medical Group Association

The American Medical Group Association (AMGA) today announced that the recipient of the 2012 AMGA Acclaim Award is HealthPartners for "Triple Aim 2.0: Designing Culture to Support Better Health, Better Experience at a Lower Cost," an inventive and patient-centered approach to align the Institute of Medicine's Aims to identify and drive performance improvement, innovation, and culture throughout the organization.

29 Aug 2012

Deep-brain stimulation may stop uncontrollable shaking in patients with Parkinson's

Deep-brain stimulation (DBS) may stop uncontrollable shaking in patients with Parkinson's disease and essential tremor by imposing its own rhythm on the brain, according to two studies published recently by University of Alabama at Birmingham researchers in the journal Movement Disorders.

29 Aug 2012

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.

29 Aug 2012

NYU-Poly creates ultra-sensitive biosensor to identify small single virus particles

Researchers at Polytechnic Institute of New York University (NYU-Poly) have created an ultra-sensitive biosensor capable of identifying the smallest single virus particles in solution, an advance that may revolutionize early disease detection in a point-of-care setting and shrink test result wait times from weeks to minutes.

29 Aug 2012

MMV390048 shows potent activity against multiple points in malaria parasite's lifecycle

A recently discovered compound from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at the University of Cape Town, South Africa.

29 Aug 2012

Scientists identify genes that underlie growth of primitive leukemia stem cells

University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cells, and then to use the new genetic signature to identify currently available drugs that selectively target the rogue cells.

29 Aug 2012

NUI Galway project hopes to deliver cost effective tool for rapid diagnosis of pneumonia

Researchers at NUI Galway are involved in a new European project which hopes to deliver a cost effective tool for the speedy diagnosis of infections such as pneumonia. The test would reduce diagnosis time from days to hours, so that the appropriate treatments can be administered as early as possible for the best possible outcome.

29 Aug 2012

DRG Diagnostics, BIT Analytical Instruments to launch new product

BIT Analytical Instruments, a complete contract product development, manufacturing services and after-sales service provider to medical and industrial instrument OEM clients, partnered with DRG Diagnostics to launch a revolutionary new product - the DRG:HYBRID XL Analyzer, a fully-automated and integrated random-access analyzer for immunoassays and clinical chemistry.

29 Aug 2012

St. Jude’s EnligHTN renal denervation system safe and effective in treating resistant hypertension

St. Jude Medical, Inc., a global medical device company, today announced that interim data demonstrated the company's EnligHTN renal denervation system is safe and effective for the treatment of resistant hypertension.

29 Aug 2012

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help "keep track of whether a patient is taking their medicine on time," Reuters reports.

29 Aug 2012

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

29 Aug 2012

Merit Medical Systems, Catheter Connections enter DualCap distribution agreement

Catheter Connections, Inc., a leading developer of disposable devices for preventing blood stream infections caused by vascular access devices, today announced that it entered into an exclusive distribution agreement with Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology.

29 Aug 2012

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on cancer vaccines and a discussion on best approaches for the future.

28 Aug 2012

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.

28 Aug 2012

Edge CT now available in NYU Langone's Department of Radiology clinical practice

NYU Langone Medical Center is the first in the country to offer patients access to the new Siemens Somatom Definition Edge single-source computed tomography system (Edge CT), one of the world's fastest CT scanners capable of generating high quality, 3-D diagnostic images using extremely low radiation.

28 Aug 2012

Process for setting new global development goals should be open, inclusive

In this CNN opinion piece, Jamie Drummond, co-founder and executive director of ONE, notes the 2015 deadline for the Millennium Development Goals (MDGs) is approaching, assesses progress towards these goals and examines issues surrounding the creation of a new set of goals.

28 Aug 2012

Researchers now add electronic sensors to tissue scaffolds

To control the three-dimensional shape of engineered tissue, researchers grow cells on tiny, sponge-like scaffolds. These devices can be implanted into patients or used in the lab to study tissue responses to potential drugs.

28 Aug 2012

Control of siRNA could aid regenerative medicine, cancer therapy

Some of the body's own genetic material, known as small interfering RNA (siRNA), can be packaged then unleashed as a precise and persistent technology to guide cell behavior, researchers at Case Western Reserve University report in the current issue of the journal, Acta Biomaterialia.

28 Aug 2012

Technology News and Research

Anova Cancer Care to participate in CyberKnife research study

Johns Hopkins' Armstrong Institute for Patient Safety and Quality receives Moore Foundation grant

HealthPartners receives Acclaim Award from American Medical Group Association

Deep-brain stimulation may stop uncontrollable shaking in patients with Parkinson's

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

NYU-Poly creates ultra-sensitive biosensor to identify small single virus particles

MMV390048 shows potent activity against multiple points in malaria parasite's lifecycle

Scientists identify genes that underlie growth of primitive leukemia stem cells

NUI Galway project hopes to deliver cost effective tool for rapid diagnosis of pneumonia

DRG Diagnostics, BIT Analytical Instruments to launch new product

St. Jude’s EnligHTN renal denervation system safe and effective in treating resistant hypertension

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Merit Medical Systems, Catheter Connections enter DualCap distribution agreement

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Edge CT now available in NYU Langone's Department of Radiology clinical practice

Process for setting new global development goals should be open, inclusive

Researchers now add electronic sensors to tissue scaffolds

Control of siRNA could aid regenerative medicine, cancer therapy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News